Abstract:Objective: Pancreatic cancer has a poor prognosis due to its high malignancy and rapid progression. The limited immunogenicity of pancreatic cancer (PAAD) contributes to its low responsiveness to immunotherapy, yet its underlying mechanism remains poorly understood. As a cancer promoting gene, Twist participates in EMT in various tumors and promotes tumor progression. The interplay between EMT and the tumor microenvironment (TME) emerges as a pivotal factor influencing tumor immunity and response to immunotherapy. Twist therefore has potential as a biomarker for gauging the outcome of tumour immunotherapy.This research aimed to assess the Twist's prognostic significance in PAAD and its relationship to immunotherapy response. Methods: In this research, transcriptional data and epigenetic alterations of Twist in pancreatic cancer, along with their impact on the prognosis of PAAD patients, were analyzed using databases. Functional enrichment analysis elucidated the biological role of Twist in PAAD. Subsequently, databases including CIBERSORT and TIDE were employed to investigate the association between Twist expression and immune cell infiltration, immune checkpoint genes, and immunotherapy sensitivity within the pancreatic cancer immune microenvironment.Paraffinized specimens from patients with pancreatic ductal adenocarcinoma confirmed by postoperative pathology were selected for Twist expression verification, and the difference was analyzed by Chi-square test; uncontaminated pancreatic cancer cell lines were used for Twist expression verification, and the differences were analyzed by Student t-test. Results: Twist mRNA expression was notably upregulated in PAAD, positively correlating with gene methylation levels. Analyses of Kaplan-Meier and Cox regression showed a correlation between better overall survival and lower Twist expression. Functional annotation indicated that Twist-associated differentially expressed genes (DEGs) were involved in EMT regulation and acute inflammation. High expression of Twist leads to a significant reduction in the infiltration of anti-tumor immune cells such as Monocytes, NKcellsactivated, and TcellsCD8, further supporting its creation of a typical immunosuppressive microenvironment in pancreatic cancer. Twist expression is positively correlated with the expression of HARVCR2, LAIR1, LGALS3 and other genes, which may be related to the treatment response to immune checkpoint inhibitors (ICIs). TIDE analysis predicts that patients with high expression of Twist will be insensitive to immunotherapy. Twist is significantly over-expressed in pancreatic cancer cell lines and tissues, and is negatively correlated with E-cadhrin expression, but positively correlated with N-cadherin,Snail, and ZEB1. Conclusion: High Twist expression in PAAD signifies a grim prognosis. Its elevated levels not only contribute to tumor progression through EMT induction but also exert regulatory control over the immune microenvironment, leading to immunosuppression and diminished effectiveness of immunotherapy.

Research progress between the embryo development gene Twist and gynecological tumor

AKT-ions with a TWIST between EMT and MET.

Expression of Twist-1 promotes lymph node metastasis of gastric cancer cells

Relationship Between the Methylation Levels of Twist Gene and Pathogenesis of Endometriosis

Roles of Cell Migration and Invasion Mediated by Twist in Endometriosis

The expression of Twist and E -cadherin and its clinical significance in ovarian endometriosis

An Overview of Twist1 in Glioma Progression and Recurrence.

Normal and disease-related biological functions of Twist1 and underlying molecular mechanisms

Expression Pattern of WT1 mRNA in Shaoxing Duck Ovarian Follicles

The Role of TWIST1 in Epithelial-Mesenchymal Transition and Cancers

The Expression of Twist gene in Colorectal Carcinomals and relation with clinical pathological marker

The prognostic significance of twist in pancreatic cancer and its role in cancer promotion through the regulation of the immune microenvironment and EMT mechanisms

Twist Regulation of EMT and Its Clinical Significance in Monitoring Circulating Tumor Cells and Evaluating Effects of Anticancer Drugs

MiR-526b Suppresses Cell Proliferation, Cell Invasion and Epithelial-Mesenchymal Transition in Breast Cancer by Targeting Twist1

Twist2 Promotes Kidney Cancer Cell Proliferation and Invasion by Regulating ITGA6 and CD44 Expression in the ECM-receptor Interaction Pathway

Twist Mediates an Aggressive Phenotype in Human Colorectal Cancer Cells.

Prognostic Value of Twist in Lung Cancer: Systematic Review and Meta-Analysis.

The Role of XBP1s in the Metastasis and Prognosis of Hepatocellular Carcinoma

Significance of TWIST Expression and Its Association with E-cadherin in Bladder Cancer

Twist-1 Stimulates the Malignant Behaviors of Hydatidiform Mole via the PI3K/AKT Pathway

Emerging biological functions of Twist1 in cell differentiation